跳至主要内容
临床试验/NCT00921635
NCT00921635暂停3 期

A Phase III Study to Evaluate the Impact of Maintaining Haemoglobin Levels Above 120g/L Verses Above 100g/L in Anaemic Patients With Carcinoma of the Cervix Receiving Concurrent Cisplatin and Radiation Therapy

Tri-Service General Hospital0 个研究点目标入组 2 人开始时间: 2008年4月最近更新:
适应症

试验速览

阶段
3 期
状态
暂停
入组人数
2
主要终点
The impact of maintaining hemoglobin levels above 120 g/L versus above 100 g/L

研究概览

简要总结

The purpose of this study is to assess the feasibility, safety and short term effects on health related quality of life, of maintaining hemoglobin from 120 to 130 g/L versus from 100 to 110 g/L, with red cell concentrate (RCC) transfusion, in women having chemo-radiation for cancer of the cervix.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Previously untreated cervix cancer
  • FIGO stage IB2, II, IIIB, IVA
  • Suitable for treatment with radical intent using concurrent cisplatin and pelvic radiation

排除标准

  • Hemoglobin level above 125g/L
  • Lower one-third vaginal involvement
  • Para-aortic lymphadenopathy

结局指标

主要结局

The impact of maintaining hemoglobin levels above 120 g/L versus above 100 g/L

时间窗: 5 years

次要结局

未报告次要终点

研究者

申办方类型
Other

相似试验